FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pharmacology, and describes antidote of carbon monoxide and hepatotoxic substances. Antidote is ammonia-zinc salt of soluble oxidised lignin with general formula (CxHyOz)n(NH3)k(Zn)m, where x = 14-16; y = 11-13; z = 5-7; n = 1.0-20; k = 1-30; m = 1-1.2.
EFFECT: higher efficiency of treatment and prevention of poisoning with carbon monoxide (CO) and hepatotoxic agents and can be used for treating hypoxic states of various aetiology.
1 cl, 7 ex, 11 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIDOTE FOR CARBON MONOXIDE | 2015 |
|
RU2581467C1 |
USING ACIZOL AS HEPATOPROTECTING AGENT | 2004 |
|
RU2260427C1 |
METHOD OF TREATING LIVER DISEASES OF VARIOUS GENESES | 2009 |
|
RU2400233C1 |
ENCAPSULATED FORM OF ACYZOL | 2005 |
|
RU2290928C1 |
NEW COMPLEX OF BIOLOGICALLY ACTIVE COMPOUNDS OUT OF LARCH BARK NAMED PICNOLAR | 2003 |
|
RU2252028C2 |
APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
MEDICATION, REPRESENTING BETULIN BIS-ISONICOTINOATE, DEMONSTRATING ANTI-ULCER, ANTI-INFLAMMATORY AND HEPATOPROTECTIVE ACTIVITY | 2013 |
|
RU2538212C1 |
REMEDY FOR POISONING AND ITS COMPLICATIONS TREATMENT | 2006 |
|
RU2331417C1 |
ADAPTOGEN | 2004 |
|
RU2279877C2 |
ORAL PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY GASTROINTESTINAL DISEASES | 2010 |
|
RU2445965C2 |
Authors
Dates
2016-05-20—Published
2015-04-06—Filed